One Year After the Cannabis Law Reform: A Status Check

Review of the Political Debate 

Over the past year, discussions have centered on both the opportunities and challenges of the new law. A key question remains: Have the reforms led to tangible benefits for society and public health? Critics point to gaps in prevention efforts, concerns about youth protection, and potential burdens on the justice system and schools. Supporters argue that no alarming trends have emerged so far and highlight the positive effects of decriminalization, particularly for those previously stigmatized. Beyond public health, the economic impact is also significant. The medical cannabis industry continues to grow, with many mid-sized businesses successfully adapting to the new regulatory landscape. 

Medical Cannabis: Stability or Uncertainty? 

Medical cannabis access has improved with more doctors prescribing it and fewer bureaucratic hurdles for patients. However, challenges remain. Will the CanG stay in place as it is, or will further adjustments be made? The answer is critical for patients, healthcare providers, and businesses alike. 

A full rollback of the law would have major consequences—disrupting treatment for patients, creating uncertainty for doctors and pharmacies, and adding unnecessary bureaucratic complexity. However, targeted adjustments, such as refining enforcement tools to combat the illegal market, could be implemented without undoing the core reforms. 

Scientific Findings and the Road Ahead 

Early research offers some insights: Data from Stuttgart, for example, suggests no significant rise in cannabis use since the law took effect. But a comprehensive evaluation will take time. More data is needed to guide future adjustments based on real-world evidence. 

What’s Next? 

One year later, Germany has not only adapted to cannabis reform—it has proven resilient. Removing cannabis from the Narcotics Act was a crucial step in improving medical access and reducing stigma. The next phase is critical: Thoughtful decisions must be made to ensure progress continues, without political reversals that could undermine the positive developments achieved so far. 

Anything else?

Do you have specific questions or suggestions for the Cannabis Briefing? Then send us an email to briefing@cansativa.de. If you are interested in revolutionising the cannabis industry with us, then stay tuned and follow our briefings!

We wish you a good read!

Best wishes from both of us,